L-valine

Biomarker

2 papers2 findings

  • Humans1
  • Model organisms1

Interventions

1

Exercise

downin humans1

1 study
  1. Exercise decreases L-valine in humans (β=-0.23, pFDR=0.031).

    “L-valine concentrations were inversely correlated with MVPA (β=-0.23, pFDR=0.031)”

    Humansn = 754

    A cohort study of physical activity, gut microbiota, serum metabolites, and the risk of steatotic liver disease

    Annals of hepatology19 Sep 2026

More on Exercise

Associations

1

Steatotic liver disease

upin humans1OR 1.78

1 study
  1. L-valine raises the risk of steatotic liver disease in humans (OR 1.78, 95% CI 1.22-2.63).

    “demonstrating a positive association with SLD risk (OR=1.78, 95% CI: 1.22-2.63)”

    Humansn = 754

    A cohort study of physical activity, gut microbiota, serum metabolites, and the risk of steatotic liver disease

    Annals of hepatology19 Sep 2026

More on Steatotic liver disease

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months